share_log

HC Wainwright & Co. Reiterates Buy on Allogene Therapeutics, Maintains $10 Price Target

Moomoo 24/7 ·  Mar 19 06:55

HC Wainwright & Co. analyst Robert Burns reiterates Allogene Therapeutics (NASDAQ:ALLO) with a Buy and maintains $10 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment